Article ; Online: Outcome of clinical experience of introducing a patient with secondary systemic AL-amyloidosis associated with multiple myeloma.
2023 Volume 44, Issue 1, Page(s) 46–53
Abstract: This research is relevant, as AL-amyloidosis refers to a systemic type of disease characterized by aggregation of an improperly folded light chain of an immunoglobulin, mainly in the heart and kidneys, causing organ failure. This study describes the ... ...
| Abstract | This research is relevant, as AL-amyloidosis refers to a systemic type of disease characterized by aggregation of an improperly folded light chain of an immunoglobulin, mainly in the heart and kidneys, causing organ failure. This study describes the clinical experience of introducing a patient with cardiac amyloidosis associated with multiple myeloma (MM). A clinical case of a patient diagnozed with amyloidosis was considered. Magnetic resonance imaging signs of cardiac amyloidosis were confirmed due to the presence of concentric biventricular hypertrophy without dilation, atrial septal hypertrophy, a tendency to atrial dilation, thickening of valve flaps and atrial walls. Upon admission to the research institute, the patient had an anasarca. More accurate recognition of AL-amyloidosis by cardiologists allows for prescribing earlier treatment and improving results. Conventional treatment of MM and AL-amyloidosis includes a combination of dexamethasone with bortezomib and endoxan. Haematopoietic stem cell transplantation after taking high doses of melphalan has become another treatment option and has led to remission in some patients. The novelty of the study is that an example of a timely complete diagnosis and treatment of a combination of these two diseases was presented, as a result of which the patient has achieved a complete haematological and partial organ response to the underlying disease. |
|||||
|---|---|---|---|---|---|---|
| MeSH term(s) | Humans ; Multiple Myeloma/complications ; Multiple Myeloma/drug therapy ; Atrial Fibrillation/complications ; Amyloidosis/complications ; Amyloidosis/diagnosis ; Amyloidosis/drug therapy ; Immunoglobulin Light-chain Amyloidosis/complications ; Hypertrophy/complications ; Treatment Outcome | |||||
| Language | English | |||||
| Publishing date | 2023-01-16 | |||||
| Publishing country | England | |||||
| Document type | Case Reports ; Journal Article | |||||
| ZDB-ID | 603134-1 | |||||
| ISSN | 1460-2180 ; 0143-3334 | |||||
| ISSN (online) | 1460-2180 | |||||
| ISSN | 0143-3334 | |||||
| DOI | 10.1093/carcin/bgad004 | |||||
| Shelf mark |
|
|||||
| Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
| Zs.A 1558: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (1.OG) ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.